Pharmafile Logo
Pharmafocus logo
Advanced Search

generics

Showing 15 posts of 209 posts found.

Pay-for-delay deals up 60% in US

May 6, 2011
Sales and Marketing FTC, generics

Deals to delay generic drugs from coming onto the US market have more than doubled. The Federal Trade Commission’s staff …

News
Cephalon

Cephalon accepts Teva’s $6.8 billion white knight bid

May 3, 2011
Research and Development, Sales and Marketing Cephalon, Teva, Valeant, generics

Generics giant Teva has acquired Cephalon for $6.8 billion and says the deal will make it a leading specialty pharmaceutical …

News
hamedprasadweb

Indian firm Dr Reddy’s opens UK site

April 12, 2011
Sales and Marketing Cambridge, Chirotech, Dr Reddy's, India, generics

Indian firm Dr Reddy’s has confirmed the UK is still attractive for investment as it opens its new pharma services …

News

Eisai to cut 900 jobs ahead of Aricept patent loss

March 7, 2011
Sales and Marketing Aricept, Eisai, donepezil, generics, job cuts

Eisai is to cut around 900 jobs in Europe, the US and Japan over the next five years as it …

News
Obama

Obama’s generics plan criticised

February 15, 2011
Sales and Marketing FDA, Obama, PhRMA, generics, reform

US pharma says new plans to end ‘pay-for-delay’ generics deals and shave five years from biologics exclusivity will threaten innovation …

News

Generics force Sanofi into standstill

February 9, 2011
Sales and Marketing 2010 pharma results, Jevtana, Multaq, Sanofi, Sanofi-Aventis, generics

An onslaught of generic competition combined with healthcare cuts in the US and Europe meant Sanofi-Aventis’ revenues were brought to …

News

Teva plant in Israel cited by FDA, expands in Americas

February 8, 2011
Manufacturing and Production Corporacion Infarmasa, FDA, Peru, Teva, Teva Pharmaceutical, generics, generics manufacturing, manufacturing compliance

A manufacturing facility in Jerusalem operated by Teva Pharmaceutical failed to pass muster in an FDA inspection, prompting a warning …

News

European Commission launches new generic deal review

January 18, 2011
Sales and Marketing European Commission, anti-trust investigation, competition, generics

The European Commission has asked a number of firms to submit copies of their patent settlements in 2010 to see …

News
Pfizer headquarters

Pfizer pays $63m for generics portfolio

January 5, 2011
Sales and Marketing Akorn, Akorn-Strides, Pfizer, Strides Arcolab, generics, injectables

Pfizer has bolstered its generics portfolio, paying around $63 million for 22 drugs. The company will buy 16 Abbreviated New …

News

Two thirds of pharma companies face ‘strategic crisis’

October 25, 2010
Research and Development, Sales and Marketing Novartis, Pfizer, Roland Berger, generics, pharma research, pharma sales

The pharma industry is moving away from traditional in-house innovation and toward a more diversified business model, but will encounter …

News

Government drops generic substitution plans

October 15, 2010
Sales and Marketing NHS, generics, government

The coalition government has dropped plans to implement generic substitution in England. The Pharmaceutical Price Regulation Scheme (PPRS), a scheme …

News

Generic Lovenox to dent Sanofi’s earnings

July 26, 2010
Sales and Marketing Lovenox, Sandoz, Sanofi-Aventis, generics

A generic version of Sanofi-Aventis’ blockbuster anti-blood clot treatment Lovenox has just gained approval in the US, signaling a rapid …

News

European Court upholds AZ Losec judgement

July 2, 2010
Sales and Marketing AstraZeneca, Losec, generics

The General Court of the EU has upheld the European Commission’s 2005 decision that AstraZeneca were guilty of blocking cheaper …

News

Third Apotex plant cited in FDA warning letter

April 19, 2010
Manufacturing and Production Apotex, generics, manufacturing compliance

Canada’s Apotex has been sent a warning letter citing manufacturing violations at a facility in Toronto that are identical to …

News

Novartis set to boost generic portfolio

April 19, 2010
Sales and Marketing Novartis, Sandoz, generics

Novartis’ generics arm Sandoz has signed a deal to acquire US-based inhalable drug specialist Oriel Therapeutics. Sandoz will gain rights …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026